WBC
West Branch Capital’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4K | Sell |
114
-38
| -25% | -$4.81K | ﹤0.01% | 236 |
|
|
2025
Q1 | $19.4K | Buy |
152
+51
| +50% | +$6.52K | 0.01% | 225 |
|
|
2024
Q4 | $13.4K | Sell |
101
-60
| -37% | -$7.97K | ﹤0.01% | 249 |
|
|
2024
Q3 | $23.4K | Sell |
161
-15
| -9% | -$2.18K | 0.01% | 212 |
|
|
2024
Q2 | $24.1K | Hold |
176
| – | – | 0.01% | 212 |
|
|
2024
Q1 | $24.1K | Sell |
176
-80
| -31% | -$11K | 0.01% | 214 |
|
|
2023
Q4 | $34.8K | Sell |
256
-121
| -32% | -$16.4K | 0.02% | 187 |
|
|
2023
Q3 | $46K | Hold |
377
| – | – | 0.02% | 168 |
|
|
2023
Q2 | $47.8K | Hold |
377
| – | – | 0.02% | 166 |
|
|
2023
Q1 | $48.6K | Buy |
377
+1
| +0.3% | +$129 | 0.03% | 167 |
|
|
2022
Q4 | $49.4K | Hold |
376
| – | – | 0.03% | 167 |
|
|
2022
Q3 | $44K | Sell |
376
-16
| -4% | -$1.87K | 0.03% | 176 |
|
|
2022
Q2 | $46K | Sell |
392
-8
| -2% | -$939 | 0.03% | 176 |
|
|
2022
Q1 | $52K | Sell |
400
-296
| -43% | -$38.5K | 0.02% | 184 |
|
|
2021
Q4 | $106K | Hold |
696
| – | – | 0.05% | 137 |
|
|
2021
Q3 | $113K | Buy |
696
+1
| +0.1% | +$162 | 0.05% | 124 |
|
|
2021
Q2 | $114K | Buy |
+695
| New | +$114K | 0.06% | 128 |
|
|
2019
Q2 | – | Sell |
-1,838
| Closed | -$206K | – | 93 |
|
|
2019
Q1 | $206K | Buy |
+1,838
| New | +$206K | 0.18% | 80 |
|
|
2018
Q4 | – | Sell |
-3,401
| Closed | -$415K | – | 79 |
|
|
2018
Q3 | $415K | Sell |
3,401
-1,836
| -35% | -$224K | 0.31% | 66 |
|
|
2018
Q2 | $575K | Buy |
+5,237
| New | +$575K | 0.45% | 56 |
|